ArticleAnnals of hematology2025

Treatment outcomes of zanubrutinib-based regimen in newly diagnosed patients with MYC/BCL2 double-expressor diffuse large B-cell lymphoma: a retrospective multicenter real-world study.

Bo Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.